Our findings suggest a correlation between the CXCL16-CXCR6 axis and AD pathology, but it remains unknown whether modulating this axis would affect the microglia-mediated CD8+ T cell trafficking in the brain or influence AD progression, as recently questioned54. Here, CXCR6 is linked to Alzheimer disease.